Very long-chain acyl-coenzyme A dehydrogenase deficiency |
ACADVL; acyl-CoA dehydrogenase very long chain deficiency; VLCAD deficiency; VLCAD-C; VLCAD-H |
Clinical Trial: A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
This study is currently recruiting patients.
|
Purpose
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
| Condition | Treatment or Intervention |
|---|---|
| Glucosephosphate Dehydrogenase Deficiency Favism | Drug: Primaquine |
MedlinePlus related topics: Anemia; Food Contamination and Poisoning; Genetic Disorders; Metabolic Disorders; Poisoning
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacodynamics Study
Expected Total Enrollment: 14
Study start: December 2003
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
- Not pregnant or planning pregnancy
- Have not taken any anti-malarial medication in past month
- Negative blood tests for HIV and specific types of hepatitis
- Not allergic to primaquine
- Need both G6PD-deficient volunteers and G6PD-normal volunteers
Location and Contact Information
Maryland
Walter Reed Army Institute of Research, Silver Spring, Maryland, 20910, United States; Recruiting
Oman Q Salazar 866-856-3259 clinical2@na.amedd.army.mil
In-Kyu Yoon, M.D., Principal Investigator
More Information
Recruitment page for G6PD study
Record last reviewed: March 2004
Last Updated: October 13, 2004
Record first received: January 20, 2004
ClinicalTrials.gov Identifier: NCT00076323
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


